Co-morbid tobacco use disorder and depression: A re-evaluation of smoking cessation therapy in depressed smokers

American Journal on Addictions

Volumn 24, Issue 8, 2015, Pages 687-694

  Morozova, Marya ^a   Rabin, Rachel A ^a,b   George, Tony P ^a,b,c  

^a CENTRE FOR ADDICTION AND MENTAL HEALTH   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

COMORBIDITY; FOLLOW UP; HUMAN; MAJOR DEPRESSION; MOTIVATION; QUALITY OF LIFE; REVIEW; SELF MEDICATION; SMOKING; SMOKING CESSATION; SYMPTOMATOLOGY; TOBACCO DEPENDENCE; DEPRESSIVE DISORDER, MAJOR; PREVENTION AND CONTROL; PSYCHIATRIC DIAGNOSIS; PSYCHOLOGICAL THEORY; PSYCHOLOGY; TOBACCO USE DISORDER; TREATMENT OUTCOME;

DEPRESSIVE DISORDER, MAJOR; DIAGNOSIS, DUAL (PSYCHIATRY); HUMANS; MOTIVATION; PSYCHOLOGICAL THEORY; SMOKING; SMOKING CESSATION; TOBACCO USE DISORDER; TREATMENT OUTCOME;

EID: 84955176214     PISSN: 10550496     EISSN: 15210391     Source Type: Journal    
DOI: 10.1111/ajad.12277     Document Type: Review

References (59)

1. Chambers RA, Krystal JH, Self DW. A neurobiological basis for substance abuse comorbidity in schizophrenia. Biol Psychiatry 2001;50:71-83.
2. Ziedonis DM, Zammarelli L, Seward G, et al. Addressing tobacco use through organizational change: A case study of an addiction treatment organization. J Psychoactive Drugs 2007;39:451-459.
3. George TPK. Co-morbidity of psychiatric and substance abuse disorders. Curr Opin Psychiatry 2000;13:327-331.
4. McClave AK, McKnight-Eily LR, Davis SP, et al. Smoking characteristics of adults with selected lifetime mental illnesses: Results from the 2007 National Health Interview Survey. Am J Public Health 2010;100:2464-2472.
5. Agaku IT KB Dube SR. Cigarette Smoking Among Adults-United States, 2005-2013. 2014.
6. Satcher DS. Executive summary: A report of the surgeon general on mental health. Public Health Rep 2000;115:89-101.
7. Regier DA, Farmer ME, Rae DS, et al. Comorbidity of mental disorders with alcohol and other drug abuse. Results from the Epidemiologic Catchment Area (ECA) Study. JAMA 1990;264:2511-2518.
8. Davis LL, Rush JA, Wisniewski SR, et al. Substance use disorder comorbidity in major depressive disorder: An exploratory analysis of the sequenced treatment alternatives to relieve depression cohort. Compr Psychiatry 2005;46:81-89.
9. Hasin DS, Goodwin RD, Stinson FS, et al. Epidemiology of major depressive disorder: Results from the National Epidemiologic Survey on alcoholism and related conditions. Arch Gen Psychiatry 2005;62:1097-1106.
10. Kessler RC, Nelson CB, McGonagle KA, et al. Comorbidity of DSM-III-R major depressive disorder in the general population: Results from the US National Comorbidity Survey. Br J Psychiatry Suppl 1996;30:17-30.
11. Lasser K, Boyd JW, Woolhandler S, et al. Smoking and mental illness: A population-based prevalence study. JAMA 2000;284:2606-2610.
12. Callaghan RC, Veldhuizen S, Jeysingh T, et al. Patterns of tobacco-related mortality among individuals diagnosed with schizophrenia, bipolar disorder, or depression. J Psychiatr Res 2014;48:102-110.
13. Thorndike AN, Stafford RS, Rigotti NA. US physicians' treatment of smoking in outpatients with psychiatric diagnoses. Nicotine Tob Res 2001;3:85-91.
14. Hitsman B, Borrelli B, McChargue DE, et al. History of depression and smoking cessation outcome: A meta-analysis. J Consult Clin Psychol 2003;71:657-663.
15. Schroeder SA. A 51-year-old woman with bipolar disorder who wants to quit smoking. JAMA 2009;301:522-531.
16. Hitsman B, Moss TG, Montoya ID, et al. Treatment of tobacco dependence in mental health and addictive disorders. Can J Psychiatry 2009;54:368-378.
17. Prochaska JJ. Integrating tobacco treatment into mental health settings. JAMA 2010;304:2534-2535.
18. American Psychiatric Association Diagnostic and statistical manual of mental disorders. Washington, DC: American Psychiatric Association: 2000.
19. Beck ATS, Brown GK. Manual for the Beck Depression Inventory-II. San Antonio, TX: Psychological Corporation; 1996.
20. Hamilton M. Development of a rating scale for primary depressive illness. Br J Soc Clin Psychol 1967;6:278-296.
21. da Silva Lima AF, de Almeida Fleck MP. Subsyndromal depression: An impact on quality of life?. J Affect Disord 2007;100:163-169.
22. Siru R, Hulse GK, Tait RJ. Assessing motivation to quit smoking in people with mental illness: A review. Addiction 2009;104:719-733.
23. Morris CD, Tedeschi GJ, Waxmonsky JA, et al. Tobacco quitlines and persons with mental illnesses: Perspective, practice, and direction. JAm Psychiatr Nurses Assoc 2009;15:32-40.
24. Acton GS, Prochaska JJ, Kaplan AS, et al. Depression and stages of change for smoking in psychiatric outpatients. Addict Behav 2001;26:621-631.
25. Prochaska JJ, Rossi JS, Redding CA, et al. Depressed smokers and stage of change: Implications for treatment interventions. Drug Alcohol Depend 2004;76:143-151.
26. Abrantes AM, Lee CS, MacPherson L, et al. Health risk behaviors in relation to making a smoking quit attempt among adolescents. J Behav Med 2009;32:142-149.
27. Addington J, el-Guebaly N, Addington D, et al. Readiness to stop smoking in schizophrenia. Can J Psychiatry 1997;42:49-52.
28. MacPherson L, Tull MT, Matusiewicz AK, et al. Randomized controlled trial of behavioral activation smoking cessation treatment for smokers with elevated depressive symptoms. J Consult Clin Psychol 2010;78:55-61.
29. Blalock JA, Robinson JD, Wetter DW, et al. Nicotine withdrawal in smokers with current depressive disorders undergoing intensive smoking cessation treatment. Psychol Addict Behav 2008;22:122-128.
30. Prochaska JJ, Hall SM, Tsoh JY, et al. Treating tobacco dependence in clinically depressed smokers: Effect of smoking cessation on mental health functioning. Am J Public Health 2008;98:446-448.
31. Thorsteinsson HS, Gillin JC, Patten CA, et al. The effects of transdermal nicotine therapy for smoking cessation on depressive symptoms in patients with major depression. Neuropsychopharmacology 2001;24:350-358.
32. Lyvers M, Carlopio C, Vicole Bothma H, et al. Mood, mood regulation, and frontal systems functioning in current smokers, long-term abstinent ex-smokers, and never-smokers. J Psychoactive Drugs 2014;46:133-139.
33. Kahler CW, Brown RA, Ramsey SE, et al. Negative mood, depressive symptoms, and major depression after smoking cessation treatment in smokers with a history of major depressive disorder. J Abnorm Psychol 2002;111:670-675.
34. Capron DW, Allan NP, Norr AM, et al. The effect of successful and unsuccessful smoking cessation on short-term anxiety, depression, and suicidality. Addict Behav 2014;39:782-788.
35. Berlin I, Chen H, Covey LS. Depressive mood, suicide ideation and anxiety in smokers who do and smokers who do not manage to stop smoking after a target quit day. Addiction 2010;105:2209-2216.
36. Shahab L, Andrew S, West R. Changes in prevalence of depression and anxiety following smoking cessation: Results from an international cohort study (ATTEMPT). Psychol Med 2014;44:127-141.
37. Cavazos-Rehg PA, Breslau N, Hatsukami D, et al. Smoking cessation is associated with lower rates of mood/anxiety and alcohol use disorders. Psychol Med 2014;44:2523-2535.
38. Glassman AH, Covey LS, Stetner F, et al. Smoking cessation and the course of major depression: A follow-up study. Lancet 2001;357:1929-1932.
39. Borrelli B, Niaura R, Keuthen NJ, et al. Development of major depressive disorder during smoking-cessation treatment. J Clin Psychiatry 1996;57:534-538.
40. Weinberger AH, Mazure CM, Morlett A, et al. Two decades of smoking cessation treatment research on smokers with depression:1990-2010. Nicotine Tob Res 2013;15:1014-1031.
41. Stepankova L, Kralikova E, Zvolska K, et al. Tobacco treatment outcomes in patients with and without a history of depression, Czech Republic, 2005-2010. Prev Chronic Dis 2013;10:E158.
42. Anthenelli RM, Morris C, Ramey TS, et al. Effects of varenicline on smoking cessation in adults with stably treated current or past major depression: A randomized trial. Ann Intern Med 2013;159:390-400.
43. Salin-Pascual RJ, Rosas M, Jimenez-Genchi A, et al. Antidepressant effect of transdermal nicotine patches in nonsmoking patients with major depression. J Clin Psychiatry 1996;57:387-389.
44. Smith SS, Jorenby DE, Leischow SJ, et al. Targeting smokers at increased risk for relapse: Treating women and those with a history of depression. Nicotine Tob Res 2003;5:99-109.
45. Cox LS, Patten CA, Niaura RS, et al. Efficacy of bupropion for relapse prevention in smokers with and without a past history of major depression. J Gen Intern Med 2004;19:828-834.
46. Hall SM. Nicotine interventions with comorbid populations. Am J Prev Med 2007;33:S406-S413.
47. van der Meer RM, Willemsen MC, Smit F, et al. Smoking cessation interventions for smokers with current or past depression. Cochrane Database Syst Rev 2013;8: CD006102.
48. Gierisch JM, Bastian LA, Calhoun PS, et al. Smoking cessation interventions for patients with depression: A systematic review and meta-analysis. J Gen Intern Med 2012;27:351-360.
49. Khantzian EJ. The self-medication hypothesis of addictive disorders: Focus on heroin and cocaine dependence. Am J Psychiatry 1985;142:1259-1264.
50. Boden JM, Fergusson DM, Horwood LJ. Cigarette smoking and depression: Tests of causal linkages using a longitudinal birth cohort. Br J Psychiatry 2010;196:440-446.
51. Klungsoyr O, Nygard JF, Sorensen T, et al. Cigarette smoking and incidence of first depressive episode: An 11-year, population-based follow-up study. Am J Epidemiol 2006;163:421-432.
52. Mojtabai R, Crum RM. Cigarette smoking and onset of mood and anxiety disorders. Am J Public Health 2013;103:1656-1665.
53. Steuber TL, Danner F. Adolescent smoking and depression: Which comes first?. Addict Behav 2006;31:133-136.
54. Chaiton MO, Cohen JE, O'Loughlin J, et al. A systematic review of longitudinal studies on the association between depression and smoking in adolescents. BMC public health 2009;9:356.
55. Giovino GA. The tobacco epidemic in the United States. Am J Prev Med 2007;33:S318-S326.
56. Schroeder SA, Morris CD. Confronting a neglected epidemic: Tobacco cessation for persons with mental illnesses and substance abuse problems. Annu Rev Public Health 2010;31:297-314.
57. Hollen V, Ortiz G, Schacht L, et al. Effects of adopting a smoke-free policy in state psychiatric hospitals. Psychiatr Serv 2010;61:899-904.
58. Lawn S, Campion J. Achieving smoke-free mental health services: Lessons from the past decade of implementation research. Int J Environ Res Public Health 2013;10:4224-4244.
59. Moss TG, Weinberger AH, Vessicchio JC, et al. A tobacco reconceptualization in psychiatry: Toward the development of tobacco-free psychiatric facilities. Am J Addict 2010;19:293-311.